Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Ginekologia Polska
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2023

open access

Vol 88, No 11 (2017)
Research paper
Published online: 2017-11-30
View PDF Download PDF file
Get Citation

Comparison of the effectiveness of topical silicone gel and corticosteroid cream on the pfannenstiel scar prevention — a randomized controlled trial

Elif Meseci1, Semra Kayatas2, Murat Api3, Aysen Boza4, Muzaffer Seyhan Cikman2
DOI: 10.5603/GP.a2017.0107
·
Pubmed: 29303212
·
Ginekol Pol 2017;88(11):591-598.
Affiliations
  1. Acıbadem Kozyatagı Hospital, Department of Obstetrics and Gynecology, Inonu Caddesi, Okur Sokak, No:20 Kozyatagı, 34742 Istanbul, Türkiye
  2. Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital, Department of Obstetrics and Gynecology, Uskudar Opr. Dr. Burhanettin Ustunel Cad. No:10, 34668 Istanbul, Türkiye
  3. Medipol University, Faculty of Medicine, Department of Obstetrics and Gynecology, TEM Avrupa Otoyolu Goztepe CıkıSı No: 1 Bagcılar, 34214 Istanbul, Türkiye
  4. VKV American Hospital, Department of Obstetrics and Gynecology, Guzelbahce Sok, No:20, Nisantası, 34365 Istanbul, Türkiye

open access

Vol 88, No 11 (2017)
ORIGINAL PAPERS Gynecology
Published online: 2017-11-30

Abstract

Objectives: To compare the effects of topical silicone gel and corticosteroid cream for preventing hypertrophic scar and keloid formation following Pfannenstiel incisions.

Material and methods: Fifty patients operated for benign gynecological diseases through primary Pfannenstiel incision were included. The wounds were randomly allocated to the treatment and control arms. In the treatment arm, the wounds were divided into two halves; one was treated with silicone gel and the other with methylprednisolone cream. No treat­ment was administered to the control group. Scars using the modified Vancouver Scar Scale (MVSS), patient satisfaction, and side effects were evaluated before and after (3rd month when treatment discontinued and 6th month) the treatment.

Results: Thirty-nine patients (21 patients in the treatment group and 18 patients in the control group) completed the stu­dy. Intragroup comparisons of the 3rd month and 6th month scores of the MVSS revealed that the scores of all parameters (height, pigmentation, vascularity, pliability, and total MVSS score) significantly decreased at the 6th month evaluation as compared with the 3rd month evaluation in all groups (control, silicone, and methylprednisolone groups). Multiple group comparisons at the 6th month revealed that the most prominent improvements occurred in the methylprednisolone group in all MVSS parameters as compared with the control group and in the height, vascularity, and pigmentation parameters as compared with the silicone group. No side effects were experienced by the patients with either treatment and patient satisfaction was higher in the methylprednisolone group.

Conclusion: The use of topical methylprednisolone cream in fresh wounds at the postoperative early period appears to be promising.

Abstract

Objectives: To compare the effects of topical silicone gel and corticosteroid cream for preventing hypertrophic scar and keloid formation following Pfannenstiel incisions.

Material and methods: Fifty patients operated for benign gynecological diseases through primary Pfannenstiel incision were included. The wounds were randomly allocated to the treatment and control arms. In the treatment arm, the wounds were divided into two halves; one was treated with silicone gel and the other with methylprednisolone cream. No treat­ment was administered to the control group. Scars using the modified Vancouver Scar Scale (MVSS), patient satisfaction, and side effects were evaluated before and after (3rd month when treatment discontinued and 6th month) the treatment.

Results: Thirty-nine patients (21 patients in the treatment group and 18 patients in the control group) completed the stu­dy. Intragroup comparisons of the 3rd month and 6th month scores of the MVSS revealed that the scores of all parameters (height, pigmentation, vascularity, pliability, and total MVSS score) significantly decreased at the 6th month evaluation as compared with the 3rd month evaluation in all groups (control, silicone, and methylprednisolone groups). Multiple group comparisons at the 6th month revealed that the most prominent improvements occurred in the methylprednisolone group in all MVSS parameters as compared with the control group and in the height, vascularity, and pigmentation parameters as compared with the silicone group. No side effects were experienced by the patients with either treatment and patient satisfaction was higher in the methylprednisolone group.

Conclusion: The use of topical methylprednisolone cream in fresh wounds at the postoperative early period appears to be promising.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

cicatrix, methyl prednisolonate, silicone gel, topical administration, wound healing

About this article
Title

Comparison of the effectiveness of topical silicone gel and corticosteroid cream on the pfannenstiel scar prevention — a randomized controlled trial

Journal

Ginekologia Polska

Issue

Vol 88, No 11 (2017)

Article type

Research paper

Pages

591-598

Published online

2017-11-30

Page views

4054

Article views/downloads

3958

DOI

10.5603/GP.a2017.0107

Pubmed

29303212

Bibliographic record

Ginekol Pol 2017;88(11):591-598.

Keywords

cicatrix
methyl prednisolonate
silicone gel
topical administration
wound healing

Authors

Elif Meseci
Semra Kayatas
Murat Api
Aysen Boza
Muzaffer Seyhan Cikman

References (30)
  1. van der Veer WM, Bloemen MCT, Ulrich MMW, et al. Potential cellular and molecular causes of hypertrophic scar formation. Burns. 2009; 35(1): 15–29.
    CrossRefPubMed
  2. Brissett AE, Sherris DA. Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg. 2001; 17(4): 263–272.
    CrossRefPubMed
  3. Arno AI, Gauglitz GG, Barret JP, et al. Up-to-date approach to manage keloids and hypertrophic scars: a useful guide. Burns. 2014; 40(7): 1255–1266.
    CrossRefPubMed
  4. Gold MH, Berman B, Clementoni MT, et al. Updated international clinical recommendations on scar management: part 1--evaluating the evidence. Dermatol Surg. 2014; 40(8): 817–824.
    CrossRefPubMed
  5. Gold MH, McGuire M, Mustoe TA, et al. International Advisory Panel on Scar Management. Updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment. Dermatol Surg. 2014; 40(8): 825–831.
    CrossRefPubMed
  6. Meaume S, Le Pillouer-Prost A, Richert B, et al. Management of scars: updated practical guidelines and use of silicones. Eur J Dermatol. 2014; 24(4): 435–443.
    CrossRefPubMed
  7. Chan KY, Lau CL, Adeeb SM, et al. A randomized, placebo-controlled, double-blind, prospective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound. Plast Reconstr Surg. 2005; 116(4): 1013–20; discussion 1021.
    PubMed
  8. Poetschke J, Schwaiger H, Gauglitz GG, et al. Management of keloids and hypertrophic scars: current and emerging options. Clin Cosmet Investig Dermatol. 2013; 6: 103–114.
    CrossRefPubMed
  9. Ko WJ, Na YC, Suh BS, et al. The effects of topical agent (kelo-cote or contractubex) massage on the thickness of post-burn scar tissue formed in rats. Arch Plast Surg. 2013; 40(6): 697–704.
    CrossRefPubMed
  10. Forbes-Duchart L, Marshall S, Strock A, et al. Determination of inter-rater reliability in pediatric burn scar assessment using a modified version of the Vancouver Scar Scale. J Burn Care Res. 2007; 28(3): 460–467.
    CrossRefPubMed
  11. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007; 127(3): 514–525.
    CrossRefPubMed
  12. Abergel RP, Pizzurro D, Meeker CA, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol. 1985; 84(5): 384–390.
    PubMed
  13. Hirshowitz B, Lindenbaum E, Har-Shai Y, et al. Static-electric field induction by a silicone cushion for the treatment of hypertrophic and keloid scars. Plast Reconstr Surg. 1998; 101(5): 1173–1183.
    PubMed
  14. Tandara AA, Mustoe TA. The role of the epidermis in the control of scarring: evidence for mechanism of action for silicone gel. J Plast Reconstr Aesthet Surg. 2008; 61(10): 1219–1225.
    CrossRefPubMed
  15. Shih R, Waltzman J, Evans GRD, et al. Plastic Surgery Educational Foundation Technology Assessment Committee. Review of over-the-counter topical scar treatment products. Plast Reconstr Surg. 2007; 119(3): 1091–1095.
    CrossRefPubMed
  16. Berman B, Perez OA, Konda S, et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg. 2007; 33(11): 1291–302; discussion 1302.
    CrossRefPubMed
  17. Rhee SH, Koh SH, Lee DW, et al. Aesthetic effect of silicone gel on surgical scars in Asians. J Craniofac Surg. 2010; 21(3): 706–710.
    CrossRefPubMed
  18. Medhi B, Sewal RK, Kaman L, et al. Efficacy and safety of an advanced formula silicone gel for prevention of post-operative scars. Dermatol Ther (Heidelb). 2013; 3(2): 157–167.
    CrossRefPubMed
  19. Kong CG, Kim GH, Kim DW, et al. The effect of topical scar treatment on postoperative scar pain and pruritus after total knee arthroplasty. Arch Orthop Trauma Surg. 2014; 134(4): 555–559.
    CrossRefPubMed
  20. Boyadjiev C, Popchristova E, Mazgalova J. Histomorphologic changes in keloids treated with Kenacort. J Trauma. 1995; 38(2): 299–302.
    PubMed
  21. Widgerow AD, Chait LA, Stals R, et al. New innovations in scar management. Aesthetic Plast Surg. 2000; 24(3): 227–234.
    PubMed
  22. Middelkoop E, Monstrey S, Teot L, et al. Scar Management Practical Guidelines. Maca-Cloetens; 2011 pp. : 1–109.
  23. Mustoe TA, Cooter RD, Gold MH, et al. International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg. 2002; 110(2): 560–571.
    PubMed
  24. Monstrey S, Middelkoop E, Vranckx JJ, et al. Updated scar management practical guidelines: non-invasive and invasive measures. J Plast Reconstr Aesthet Surg. 2014; 67(8): 1017–1025.
    CrossRefPubMed
  25. O'Brien L, Jones DJ. Silicone gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev. 2013(9): CD003826.
    CrossRefPubMed
  26. Sproat JE, Dalcin A, Weitauer N, et al. Hypertrophic sternal scars: silicone gel sheet versus Kenalog injection treatment. Plast Reconstr Surg. 1992; 90(6): 988–992.
    PubMed
  27. Tan E, Chua Sh, Lim J. Topical silicone gel sheet versus intralesional injections of triamcinolone acetonide in the treatment of keloids — a patient-controlled comparative clinical trial. Journal of Dermatological Treatment. 2009; 10(4): 251–254.
    CrossRef
  28. Kelemen O, Hegedus G, Kollár L, et al. [A comparative clinical study of the treatment of hypertrophic scars with either intralaesional steroid or silicone gel sheeting]. Magy Seb. 2007; 60(6): 297–300.
    CrossRefPubMed
  29. Signorini M, Clementoni MT. Clinical evaluation of a new self-drying silicone gel in the treatment of scars: a preliminary report. Aesthetic Plast Surg. 2007; 31(2): 183–187.
    CrossRefPubMed
  30. Sepehrmanesh M. Scar Management: observational study of 1522 patients using Kelo-cote, Silicone Gel. Komp Dermatologie. 2006; 1: 30–2.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl